ROTEM™ -Guided Blood Product Management for a Liver Transplant Recipient Presenting for Tracheostomy with Severe Thrombocytopenia (10/nl)

Tekin E1,2, Schumann R3, Hoyer D2 and Saner FH2*

1Department of Anesthesia and Critical Care, Gazi University, Turkey
2Department of General, Visceral and Transplant Surgery, Medical Center University Duisburg-Essen, Germany
3Department of Anesthesia, Critical Care and Pain Medicine, VA Boston Healthcare System, USA

^*Correspondance to: Fuat H Saner 

 PDF  Full Text DOI: 10.25107/2474-1647.3594

Abstract

Bleeding can be life-threatening during tracheostomy. This possibility is a major concern in liver transplant recipients with severe thrombocytopenia and hepatic coagulopathy. Point-of Care (POC) devices such as ROTEM™ provide more detailed hemostasis information than Standard Laboratory Tests (SLT). However, many liver transplant centers do not use POC coagulation assessment and elect to prophylactically transfuse platelets in the setting of severe thrombocytopenia. We present a case of ROTEM™ guided, blood product free, percutaneous tracheostomy in a liver transplant patient with severe thrombocytopenia (10/nl).

Keywords

Cite the article

Tekin E, Schumann R, Hoyer D, Saner FH. ROTEM™ -Guided Blood Product Management for a Liver Transplant Recipient Presenting for Tracheostomy with Severe Thrombocytopenia (10/nl). Clin Surg. 2022; 7: 3594..